Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature Medicine 11, 1051 - 1052 (2005)
doi:10.1038/nm1005-1051
Hitchhiker's guide to the T cell
Cliona M Rooney1
- The author is in the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas 77030, USA. e-mail: crooney@bcm.edu
Abstract
A new approach to tumor therapy combines two problematic cancer-fighting tools: tumor-targeted T cells and gene therapy. The T cells deliver a gene therapy vector to tumor cells, ensuring their destruction (pages 1073–1081).
Gene therapy to treat cancer will never reach its full potential without the availability of targeted gene-transfer vectors. Targeting must include specificity at the level of tissue, cells and DNA.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Essential role of Id2 in negative regulation of IgE class switchingNature Immunology Article (01 Jan 2003)
Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cellsNature Medicine Article (01 Oct 2005)
